Cargando…

Sports participation and physical activity in adult Dutch and Swedish patients with severe haemophilia: A comparison between intermediate‐ and high‐dose prophylaxis

INTRODUCTION: Differences in treatment and outcome have been reported for persons with haemophilia (PWH) on intermediate‐dose (Dutch) and high‐dose (Swedish) prophylaxis, but the potential influence of sports participation has not been considered. AIM: To compare sports participation and clinical ou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Versloot, Olav, Berntorp, Erik, Petrini, Pia, Ljung, Rolf, Astermark, Jan, Holmström, Margareta, de Kleijn, Piet, Fischer, Kathelijn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	ORIGINAL ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850651/ https://www.ncbi.nlm.nih.gov/pubmed/30690833 http://dx.doi.org/10.1111/hae.13683

Ejemplares similares

Sports participation and sports injuries in Dutch boys with haemophilia
por: Versloot, Olav, et al.
Publicado: (2020)

Haemophilia A and B – evaluation of the Swedish prophylactic regimen by magnetic resonance imaging
por: Lundin, Björn, et al.
Publicado: (2022)

Similar sports participation as the general population in Dutch persons with haemophilia; results from a nationwide study
por: Versloot, Olav, et al.
Publicado: (2021)

Autologous cell therapy – A new concept to eradicate inhibitors in haemophilia
por: Xie, Hanjing, et al.
Publicado: (2022)

Measurement of joint health in persons with haemophilia: A systematic review of the measurement properties of haemophilia‐specific instruments
por: Gouw, Samantha C., et al.
Publicado: (2018)

Haemophilia and joint disease: pathophysiology, evaluation, and management
por: Knobe, Karin, et al.
Publicado: (2011)

Validation of the pedHAL(short) and HAL(short) in Dutch children and adults with haemophilia
por: Kuijlaars, Isolde A. R., et al.
Publicado: (2022)

Promoting physical activity for people with haemophilia in the age of new treatments
por: Matlary, Ruth Elise D., et al.
Publicado: (2022)

Pain, depression and anxiety in people with haemophilia from three Nordic countries: Cross‐sectional survey data from the MIND study
por: Steen Carlsson, Katarina, et al.
Publicado: (2022)

Prophylaxis use of clotting factor replacement products in people with non‐severe haemophilia: A review of the literature
por: Iorio, Alfonso, et al.
Publicado: (2022)

A tailored intervention for illness acceptance improves adherence and quality of life in adults with haemophilia using prophylaxis
por: Hoefnagels, Johanna Wilhelmina, et al.
Publicado: (2021)

Association between Sports Participation, Factor VIII Levels and Bleeding in Hemophilia A
por: Bukkems, Laura H., et al.
Publicado: (2022)

Movement behaviour patterns in adults with haemophilia
por: Timmer, Merel A., et al.
Publicado: (2020)

Pain and pain management in haemophilia
por: Auerswald, Günter, et al.
Publicado: (2016)

Achieving the unimaginable: Health equity in haemophilia
por: Skinner, Mark W., et al.
Publicado: (2019)

Evaluating international Haemophilia Joint Health Score (HJHS) results combined with expert opinion: Options for a shorter HJHS
por: Kuijlaars, Isolde A.R., et al.
Publicado: (2020)

Switching treatments in haemophilia: is there a risk of inhibitor development?
por: Santagostino, Elena, et al.
Publicado: (2015)

Haemophilia A: Pharmacoeconomic Review of Prophylaxis Treatment versus On-Demand
por: Unim, Brigid, et al.
Publicado: (2015)

Medication Adherence for Haemophilia Patients: Outcome of Prophylaxis Treatment Intervention
por: Mokhtar, Fadzlin Mohd, et al.
Publicado: (2021)

Area under the curve: Comparing the value of factor VIII replacement therapies in haemophilia A
por: Persson, Sofie, et al.
Publicado: (2022)

A new paradigm for personalized prophylaxis for patients with severe haemophilia A
por: Delavenne, Xavier, et al.
Publicado: (2020)

Efficacy and safety of subcutaneous prophylaxis with dalcinonacog alfa in adults with haemophilia B
por: Mahlangu, Johnny, et al.
Publicado: (2021)

Personalised Prophylaxis in a Child with Haemophilia A and Type 1 Diabetes
por: Cruz, Maria Sol, et al.
Publicado: (2021)

Long‐term joint outcomes in adolescents with moderate or severe haemophilia A
por: Schmidt, David E., et al.
Publicado: (2022)

International consensus recommendations on the management of people with haemophilia B
por: Hart, Daniel P., et al.
Publicado: (2022)

European principles of inhibitor management in patients with haemophilia
por: Giangrande, P. L. F., et al.
Publicado: (2018)

Assessing the test–retest reliability and smallest detectable change of the Haemophilia Activities List
por: Kuijlaars, Isolde A. R., et al.
Publicado: (2020)

Programmed Sports Therapy (PST) in People with Haemophilia (PwH) “Sports Therapy Model for Rare Diseases”
por: Hilberg, Thomas
Publicado: (2018)

Surgical outcomes in patients with haemophilia A or B receiving extended half‐life recombinant factor VIII and IX Fc fusion proteins: Real‐world experience in the Nordic countries
por: Lehtinen, Anna‐Elina, et al.
Publicado: (2022)

Targeted re-sequencing of F8, F9 and VWF: Characterization of Ion Torrent data and clinical implications for mutation screening
por: Manderstedt, Eric, et al.
Publicado: (2019)

Detection of mosaics in hemophilia A by deep Ion Torrent sequencing and droplet digital PCR
por: Manderstedt, Eric, et al.
Publicado: (2020)

Shortening the Haemophilia Activities List (HAL) from 42 items to 18 items
por: Kuijlaars, Isolde A. R., et al.
Publicado: (2021)

Quality of life in a large multinational haemophilia B cohort (The B‐Natural study) – Unmet needs remain
por: Berntorp, Erik, et al.
Publicado: (2022)

Hæmophilia
Publicado: (1905)

Hæmophilia
por: Ruggles, S. D.
Publicado: (1902)

Hæmophilia
por: Porter, Charles A.
Publicado: (1900)

Adherence to Prophylaxis in Adolescents and Young Adults with Severe Haemophilia: A Quantitative Study with Patients
por: van Os, Sandra B., et al.
Publicado: (2017)

Inhibitors in haemophilia A and B: Management of bleeds, inhibitor eradication and strategies for difficult‐to‐treat patients
por: Ljung, Rolf, et al.
Publicado: (2018)

A qualitative study on the experiences of haemophilia carriers before, during and after pregnancy
por: Punt, Marieke C., et al.
Publicado: (2021)

Randomized comparison of prophylaxis and on-demand regimens with FEIBA NF in the treatment of haemophilia A and B with inhibitors
por: Antunes, S V, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_d7c58uo2o97uj3m6aubv0i2fel